PT - JOURNAL ARTICLE AU - Yi Zhe Wang AU - Wei Zhao AU - Priya Moorjani AU - Alden L. Gross AU - Xiang Zhou AU - Aparajit B. Dey AU - Jinkook Lee AU - Jennifer A. Smith AU - Sharon L.R. Kardia TI - Effect of <em>APOE</em> ε4 and its modification by sociodemographic characteristics on cognitive measures in South Asians from LASI-DAD AID - 10.1101/2024.01.04.24300840 DP - 2024 Jan 01 TA - medRxiv PG - 2024.01.04.24300840 4099 - http://medrxiv.org/content/early/2024/01/04/2024.01.04.24300840.short 4100 - http://medrxiv.org/content/early/2024/01/04/2024.01.04.24300840.full AB - BACKGROUND We investigated effects of APOE ε4 and its interactions with sociodemographic characteristics on cognitive measures in 2,563 South Asians from the Diagnostic Assessment of Dementia for the Longitudinal Aging Study of India (LASI-DAD).METHODS Linear regression models were used to assess the association between APOE ε4 and global- and domain-specific cognitive function. Effect modification by age, sex, and education were explored using cross-product interaction terms and subgroup analyses.RESULTS APOE ε4 was inversely associated with most cognitive measures. This association was stronger in the older age group (age &gt;68) for general cognitive function, orientation, and language/fluency, as well as in females for memory and language/fluency. Interaction between APOE ε4 and education was mostly nonsignificant.DISCUSSION APOE ε4 is associated with lower cognitive function in South Asians from India, with a more pronounced impact observed in females and older individuals.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project is funded by the National Institute on Aging (R01 AG051125, U01 AG065948). The study sponsor had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board at the University of Southern California gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesWhole genome sequencing data for the Diagnostic Assessment of Dementia for the Longitudinal Aging Study of India is available from the National Institute on Aging Genetics of Alzheimer's Disease Data Storage Site (NIAGADS), accession number: NG00067. Phenotype data is available at the Gateway to Global Aging website, https://g2aging.org/. https://g2aging.org/ https://dss.niagads.org/datasets/ng00067/